Caught in the Akt: Regulation of Wnt Signaling in the Intestine

Overview

Journal Gastroenterology

Specialty Gastroenterology

Date 2010 Jul 28

PMID 20659460

Citations 27

Authors

Eric C Anderson

Melissa H Wong

Affiliations

Soon will be listed here.

Citing Articles

International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.

Burris T, de Vera I, Cote I, Flaveny C, Wanninayake U, Chatterjee A Pharmacol Rev. 2023; 75(6):1233-1318.

PMID: 37586884 PMC: 10595025. DOI: 10.1124/pharmrev.121.000436.

Targeting macrophage autophagy for inflammation resolution and tissue repair in inflammatory bowel disease.

Wang E, Wu M, Ren Z, Zheng Y, Ye R, Tan C Burns Trauma. 2023; 11:tkad004.

PMID: 37152076 PMC: 10157272. DOI: 10.1093/burnst/tkad004.

Therapeutic Efficacy of Novel HDAC Inhibitors SPA3052 and SPA3074 against Intestinal Inflammation in a Murine Model of Colitis.

Yoon J, Cho H, Jeon R, Sung M Pharmaceuticals (Basel). 2022; 15(12).

PMID: 36558966 PMC: 9785328. DOI: 10.3390/ph15121515.

WNT4 overexpression and secretion in thymic epithelial tumors drive an autocrine loop in tumor cells .

Zhang X, Schalke B, Kvell K, Kriegsmann K, Kriegsmann M, Graeter T Front Oncol. 2022; 12:920871.

PMID: 35965500 PMC: 9372913. DOI: 10.3389/fonc.2022.920871.

Xianglian Pill Suppresses Inflammation and Protects Intestinal Epithelial Barrier by Promoting Autophagy in DSS Induced Ulcerative Colitis Mice.

Wang B, Gong Z, Zhan J, Yang L, Zhou Q, Yuan X Front Pharmacol. 2021; 11:594847.

PMID: 33584273 PMC: 7872966. DOI: 10.3389/fphar.2020.594847.

References

Ng S, Mahmoudi T, Danenberg E, Bejaoui I, de Lau W, Korswagen H . Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade. J Biol Chem. 2009; 284(51):35308-13. PMC: 2790960. DOI: 10.1074/jbc.M109.078261. View

Kwak Y, Song C, Yi H, Hwang P, Kim J, Lee K . Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest. 2003; 111(7):1083-92. PMC: 152583. DOI: 10.1172/JCI16440. View

Lee D, Kuo H, Chen C, Hsu J, Chou C, Wei Y . IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell. 2007; 130(3):440-55. DOI: 10.1016/j.cell.2007.05.058. View

Rychahou P, Kang J, Gulhati P, Doan H, Chen L, Xiao S . Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis. Proc Natl Acad Sci U S A. 2008; 105(51):20315-20. PMC: 2629319. DOI: 10.1073/pnas.0810715105. View

Bellacosa A, Kumar C, Di Cristofano A, Testa J . Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res. 2005; 94:29-86. DOI: 10.1016/S0065-230X(05)94002-5. View

Fedorak R, Gangl A, Elson C, Rutgeerts P, Schreiber S, Wild G . Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology. 2000; 119(6):1473-82. DOI: 10.1053/gast.2000.20229. View

Dimmeler S, Aicher A, Vasa M, Adler K, Tiemann M, Rutten H . HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest. 2001; 108(3):391-7. PMC: 209365. DOI: 10.1172/JCI13152. View

Li F, Mofunanya A, Harris K, Takemaru K . Chibby cooperates with 14-3-3 to regulate beta-catenin subcellular distribution and signaling activity. J Cell Biol. 2008; 181(7):1141-54. PMC: 2442201. DOI: 10.1083/jcb.200709091. View

Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

10.

Carpten J, Faber A, Horn C, Donoho G, Briggs S, Robbins C . A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature. 2007; 448(7152):439-44. DOI: 10.1038/nature05933. View

11.

Katoh M, Katoh M . WNT signaling pathway and stem cell signaling network. Clin Cancer Res. 2007; 13(14):4042-5. DOI: 10.1158/1078-0432.CCR-06-2316. View

12.

Sen M, Ghosh G . Transcriptional outcome of Wnt-Frizzled signal transduction in inflammation: evolving concepts. J Immunol. 2008; 181(7):4441-5. DOI: 10.4049/jimmunol.181.7.4441. View

13.

Wee K, Surana U, Aguda B . Oscillations of the p53-Akt network: implications on cell survival and death. PLoS One. 2009; 4(2):e4407. PMC: 2634840. DOI: 10.1371/journal.pone.0004407. View

14.

Dahan S, Roda G, Pinn D, Roth-Walter F, Kamalu O, Martin A . Epithelial: lamina propria lymphocyte interactions promote epithelial cell differentiation. Gastroenterology. 2007; 134(1):192-203. PMC: 2975902. DOI: 10.1053/j.gastro.2007.10.022. View

15.

Liu P, Cheng H, Roberts T, Zhao J . Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov. 2009; 8(8):627-44. PMC: 3142564. DOI: 10.1038/nrd2926. View

16.

Zisman T, Rubin D . Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol. 2008; 14(17):2662-9. PMC: 2709054. DOI: 10.3748/wjg.14.2662. View

17.

Bates R, Edwards N, Burns G, Fisher D . A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res. 2001; 61(13):5275-83. View

18.

Ericson K, Gan C, Cheong I, Rago C, Samuels Y, Velculescu V . Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation. Proc Natl Acad Sci U S A. 2010; 107(6):2598-603. PMC: 2823889. DOI: 10.1073/pnas.0914018107. View

19.

Ito H, Takazoe M, Fukuda Y, Hibi T, Kusugami K, Andoh A . A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology. 2004; 126(4):989-96. DOI: 10.1053/j.gastro.2004.01.012. View

20.

DHaens G, Baert F, Van Assche G, Caenepeel P, Vergauwe P, Tuynman H . Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet. 2008; 371(9613):660-667. DOI: 10.1016/S0140-6736(08)60304-9. View